Larimar Therapeutics (LRMR) News Today → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free LRMR Stock Alerts $6.44 +0.11 (+1.74%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEquities Analysts Set Expectations for Larimar Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:LRMR)marketbeat.com - April 5 at 8:06 AMEquities Analysts Set Expectations for Larimar Therapeutics, Inc.'s FY2026 Earnings (NASDAQ:LRMR)marketbeat.com - April 4 at 9:45 AMLarimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Rating of "Buy" from Brokeragesmarketbeat.com - April 4 at 8:39 AMLarimar Therapeutics (NASDAQ:LRMR) Earns "Outperform" Rating from Leerink Partnrsmarketbeat.com - April 4 at 8:30 AMLarimar Therapeutics (NASDAQ:LRMR) Shares Gap Up to $7.36marketbeat.com - April 3 at 4:51 PMLarimar Therapeutics (NASDAQ:LRMR) Research Coverage Started at SVB Leerinkmarketbeat.com - April 3 at 8:18 AMLarimar Therapeutics (NASDAQ:LRMR) Trading 8.1% Higher marketbeat.com - March 28 at 7:27 PMLarimar Therapeutics, Inc. (NASDAQ:LRMR) Short Interest Up 221.6% in Marchmarketbeat.com - March 27 at 10:36 PMJMP Securities Reiterates Market Outperform Rating for Larimar Therapeutics (NASDAQ:LRMR)marketbeat.com - March 18 at 6:51 PM5 Stocks that Analysts Love in March 2024msn.com - March 18 at 1:30 PMShort Interest in Larimar Therapeutics, Inc. (NASDAQ:LRMR) Drops By 18.0%marketbeat.com - March 17 at 11:48 PMLRMR Apr 2024 10.000 callfinance.yahoo.com - March 16 at 3:34 PMBuy Rating Justified: Larimar Therapeutics’ Advancements Towards FDA Approval for FA Drug Nomlabofuspmarkets.businessinsider.com - March 16 at 1:56 AMLRMR Stock Earnings: Larimar Therapeutics Misses EPS for Q4 2023investorplace.com - March 14 at 10:04 PMLarimar: Q4 Earnings Snapshotsfgate.com - March 14 at 7:48 PMRecap: Larimar Therapeutics Q4 Earningsbenzinga.com - March 14 at 7:48 PMLarimar Therapeutics Inc (LRMR) Reports Full Year and Q4 2023 Financial Resultsfinance.yahoo.com - March 14 at 7:48 PMLarimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Developmentglobenewswire.com - March 14 at 4:05 PMBuy Rating on Larimar Therapeutics Backed by Promising Drug Progress for Friedreich’s Ataxiamarkets.businessinsider.com - March 12 at 7:37 PM3 Best Stocks to Buy Now, 3/12/2024, According to Top Analystsmsn.com - March 12 at 2:33 PMAnalysts Are Bullish on These Healthcare Stocks: ACADIA Pharmaceuticals (ACAD), Larimar Therapeutics (LRMR)markets.businessinsider.com - March 12 at 8:22 AMLarimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich’s Ataxiafinance.yahoo.com - March 11 at 5:20 PMLarimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich's Ataxiaglobenewswire.com - March 11 at 4:05 PMLarimar Therapeutics to Present at Global Biopharma Conference in Miamimsn.com - March 11 at 12:20 PMAdage Capital Partners GP L.L.C. Purchases 525,000 Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR)marketbeat.com - March 11 at 6:42 AMLarimar Therapeutics to Present at the Leerink Partners Global Biopharma Conferenceglobenewswire.com - March 6 at 4:05 PMLarimar Therapeutics, Inc. (NASDAQ:LRMR) Shares Sold by Acadian Asset Management LLCmarketbeat.com - March 4 at 5:28 AMLocal life sciences companies reeled in more than $750M in stock sales in first two months of 2024bizjournals.com - March 3 at 6:23 PMLarimar Therapeutics (NASDAQ:LRMR) Trading Down 4.8%marketbeat.com - February 27 at 12:31 PMLRMR Mar 2024 17.500 callfinance.yahoo.com - February 23 at 3:56 PMLRMR Apr 2024 10.000 putfinance.yahoo.com - February 23 at 3:56 PMLarimar Therapeutics (NASDAQ:LRMR) Rating Reiterated by Lifesci Capitalmarketbeat.com - February 23 at 6:35 AMFY2023 Earnings Estimate for Larimar Therapeutics, Inc. (NASDAQ:LRMR) Issued By Lifesci Capitalmarketbeat.com - February 23 at 6:34 AMLRMR Mar 2024 25.000 callfinance.yahoo.com - February 22 at 11:42 PMBuy Rating Affirmed: Larimar Therapeutics’ Nomlabofusp Shows Potential in Friedreich’s Ataxia Treatmentmarkets.businessinsider.com - February 21 at 4:15 PMInsider Trading: Larimar’s (NASDAQ:LRMR) Director Makes an Enormous Purchasemsn.com - February 19 at 9:07 AMLRMR Mar 2024 15.000 putfinance.yahoo.com - February 19 at 12:13 AMLarimar Therapeutics Raises $172.5 Million in Public Offering to Propel Rare Disease Researchmsn.com - February 18 at 9:11 AMLarimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Sharesfinance.yahoo.com - February 16 at 9:11 PMLarimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Sharesglobenewswire.com - February 16 at 4:20 PMInsider Buying: Larimar Therapeutics, Inc. (NASDAQ:LRMR) Director Buys 4,290,617 Shares of Stockmarketbeat.com - February 16 at 3:40 PMLRMR Feb 2024 15.000 callfinance.yahoo.com - February 15 at 2:01 PMLRMR Feb 2024 10.000 putfinance.yahoo.com - February 15 at 9:01 AMLarimar Therapeutics, Inc. (NASDAQ:LRMR) Forecasted to Post Q1 2024 Earnings of ($0.30) Per Sharemarketbeat.com - February 15 at 7:52 AMLRMR May 2024 7.500 callfinance.yahoo.com - February 15 at 12:47 AMLRMR Aug 2024 2.500 putfinance.yahoo.com - February 15 at 12:47 AMDTSS, TNON and BREA among mid-day moversseekingalpha.com - February 14 at 2:46 PMLarimar Therapeutics rises after pricing $150M stock offeringmsn.com - February 14 at 2:46 PMLarimar Therapeutics (NASDAQ:LRMR) Reaches New 1-Year High After Analyst Upgrademarketbeat.com - February 14 at 12:34 PMLarimar Therapeutics Shares Climb After Public Offering Pricedmarketwatch.com - February 14 at 9:46 AM Get Larimar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LRMR and its competitors with MarketBeat's FREE daily newsletter. Email Address If you have $2,500 bucks… check this out (Ad)This computer whiz has been averaging 234% per year with an undefeated strategy he calls… The “Income Glitch” And he’s been making out like a bandit with a 100% success rate on over 64 trade opportunities! Click here to unlock the Income Glitch training workshop for free. LRMR Media Mentions By Week LRMR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LRMR News Sentiment▼0.000.32▲Average Medical News Sentiment LRMR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LRMR Articles This Week▼02▲LRMR Articles Average Week Get Larimar Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LRMR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Annexon News Fulcrum Therapeutics News Avid Bioservices News Mersana Therapeutics News Travere Therapeutics News Theravance Biopharma News Neurogene News Heron Therapeutics News Oculis News Harrow Health News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LRMR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Larimar Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
